Results 51 to 60 of about 26,031 (166)

Leptomeningeal Enhancement without Thalamic Involvement as an Initial Manifestation of Japanese Encephalitis: A Case Report

대한영상의학회지, 2021
Japanese encephalitis (JE) is a common infection caused by the Japanese encephalitis virus in Southeast Asia, which is transmitted to humans through Culex mosquitoes. Magnetic resonance imaging (MRI) is used to diagnose JE, which is often characterized
Sang Hwa Woo, Ho-Joon Lee, Yeonah Kang
doaj   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Acute Encephalitis Syndrome Surveillance, Kushinagar District, Uttar Pradesh, India, 2011–2012

Emerging Infectious Diseases, 2013
In India, quality surveillance for acute encephalitis syndrome (AES), including laboratory testing, is necessary for understanding the epidemiology and etiology of AES, planning interventions, and developing policy.
Manish Kakkar, Elizabeth T. Rogawski, Syed Shahid Abbas, Sanjay Chaturvedi, Tapan N. Dhole, Shaikh Shah Hossain, Sampath K. Krishnan   +6 more
doaj   +1 more source

A Transcriptomic Analysis of Cancer‐Stromal Interactome in Lung Cancer Xenograft Models

Cancer Science, EarlyView.
We conducted a comprehensive analysis of the lung cancer interactome to identify key ligand–receptor pairs involved in the aggressiveness of lung adenocarcinoma. Tumor necrosis factor superfamily member 12 and its receptor tumor necrosis factor receptor superfamily member 12A signaling axis may be potential candidates for therapeutic intervention for ...
Yuriko Takayama‐Isagawa, Daisuke Komura, Takayuki Isagawa, Yusuke Amano, Atsushi Kihara, Tamaki Miura, Taichiro Yoshimoto, Hiroyoshi Tsubochi, Kazutaka Fujita, Koichi Hagiwara, Makoto Maemondo, Tetsuo Ushiku, Shumpei Ishikawa, Noriyoshi Fukushima, Kentaro Inamura, Daisuke Matsubara, Toshiro Niki   +16 more
wiley   +1 more source

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

Cancer Science, EarlyView.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Toyofumi F. Chen‐Yoshikawa, Yasushi Goto, Wataru Nishio, Shizuka Nakagawa, Morihiko Hayashi, Hirotsugu Kenmotsu   +9 more
wiley   +1 more source

Opsoclonus‐Myoclonus‐Ataxia Syndrome Associated with Coexisting Anti‐N‐Methyl‐D‐Aspartate Receptor and Glial Fibrillary Acidic Protein Antibodies

Movement Disorders Clinical Practice, EarlyView.
Eriko Igami, Yutaka Oji, Akihiro Yamaguchi, Shin‐ichi Ueno, Yuji Tomizawa, Taiji Tsunemi, Taku Hatano, Nobutaka Hattori   +7 more
wiley   +1 more source

Global, regional and national burden of epilepsy in children and adolescents, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

European Journal of Clinical Investigation, EarlyView.
Globally, in 2021, there were 18.15 million prevalent cases of epilepsy in children and adolescents (8.24 and 9.91 million of idiopathic and secondary epilepsy, respectively). Between 1990 and 2021, the prevalence rate of secondary epilepsy increased by 16.14%, with especially high increases attributable to neonatal encephalopathy, neonatal jaundice ...
Yun Seo Kim, Min Seo Kim, Seoyeon Park, Lee Smith, Joaquim Radua, Sarah Soyeon Oh, Stefania I. Papatheodorou, Hoon‐Chul Kang, Ara Ko, Dong Keon Yon, Jae Il Shin   +10 more
wiley   +1 more source

Japanese encephalitis: a review of the Indian perspective

Brazilian Journal of Infectious Diseases, 2012
Japanese encephalitis virus (JEV) causes Japanese encephalitis, which is a leading form of viral encephalitis in Asia, with around 50,000 cases and 10,000 deaths per year in children below 15 years of age.
Sarika Tiwari, Rishi Kumar Singh, Ruchi Tiwari, Tapan N. Dhole   +3 more
doaj   +3 more sources

A global perspective on transitioning from pediatric to adult care in epilepsy

Epilepsia, EarlyView.
Abstract Objective Transition planning in epilepsy is crucial to ensure continuity of care, particularly for adolescents with complex needs, yet global practices remain undefined. The International League Against Epilepsy Transition Task Force (ILAE TTF) aimed to evaluate worldwide practices, barriers, and provider perspectives on transitioning ...
Danielle M. Andrade, Nathalie Jetté, Ilakkiah Chandran, Puja Patel, Guido Rubboli, J. Helen Cross, Dana Craiu, Chong Tin Tan, Edward Kija, Eva Fung, Tiziana Granata, Hassan Hosny, Marco Mula, Kate Riney, Renée A. Shellhaas, Maria Siddiqui, Quratulain Zulfiqar Ali, Julien Hébert, Paula Marques, Bronte Kerrigan, Caihong Ji, Kette Valente, Jaime Carrizosa, Rima Nabbout   +23 more
wiley   +1 more source

Strategi Pencegahan Japanese Encephalitis (JE) Melalui Vaksinasi pada Anak Usia Dini di Wilayah Endemis

Dharma
Japanese Encephalitis (JE) is an infectious disease of the central nervous system caused by the Japanese Encephalitis Virus (JEV), JEV is the main cause of viral encephalitis in Asia. This virus is transmitted by mosquitoes and is zoonotic.
Siti Naimah, Jennifa Jennifa
doaj   +1 more source